Company / Operating Income
GeneDx Holdings Corp. Operating Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$13.1M
FY2025
5-year range
-$446.1M / -$13.1M
FY2021-FY2025
Trend
+43.7%
vs FY2024
Sector context
#110 of 156
Health Care
What the data says
At -$13M, GeneDx Holdings Corp.'s operating income ranks #110 of 156 in the Health Care sector. Operating Income has increased for 4 consecutive years, from -$446M in FY2021 to -$13M in FY2025.
Based on SEC 10-K filings.
-$13M in FY2025.
Improved from -$181M to -$13M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#110 of 156 in Health CareTop 71% of 156This company -$13.1M Sector average $733.1M
▼
-101.8% below sector average
Key checks
Key Insights
- GeneDx Holdings Corp.'s operating income has grown for 4 consecutive years.
- In FY2025, operating income increased 43.7% year-over-year.
- Ranks #110 out of 156 companies in the Health Care sector.
- Lowest operating income in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$13.1M | +43.7% |
| FY2024 | -$23.2M | +87.1% |
| FY2023 | -$180.6M | +25.4% |
| FY2022 | -$242.0M | +45.8% |
| FY2021 | -$446.1M | -84.4% |
| FY2020 | -$242.0M | -695.7% |
| FY2019 | -$30.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026